A carregar...
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
BACKGROUND: This is an update of the 2009 Cochrane overview and network meta‐analysis (NMA) of biologics for rheumatoid arthritis (RA). OBJECTIVES: To assess the benefits and harms of nine biologics (abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, rituximab, t...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2016
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7068903/ https://ncbi.nlm.nih.gov/pubmed/27175934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012183 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|